| Record Information |
|---|
| Version | 2.0 |
|---|
| Created at | 2022-04-27 22:17:54 UTC |
|---|
| Updated at | 2024-09-03 04:17:22 UTC |
|---|
| NP-MRD ID | NP0050869 |
|---|
| Natural Product DOI | https://doi.org/10.57994/1011 |
|---|
| Secondary Accession Numbers | None |
|---|
| Natural Product Identification |
|---|
| Common Name | Evodiamine |
|---|
| Description | Evodiamine belongs to the class of organic compounds known as beta carbolines. Beta carbolines are compounds containing a 9H-pyrido[3,4-b]indole moiety. Evodiamine is found in Araliopsis tabouensis, Corydalis yanhusuo , Tetradium ruticarpum, Evodia rutaecarpa , Fagara rhetza (Roxb.) DC , Phellodendron amurense and Phellodendron chinense. Evodiamine was first documented in 2022 (PMID: 35463684). Based on a literature review a small amount of articles have been published on Evodiamine (PMID: 35435667) (PMID: 35388733) (PMID: 35385268) (PMID: 35379148). |
|---|
| Structure | CN1[C@H]2N(CCC3=C2NC2=CC=CC=C32)C(=O)C2=C1C=CC=C2 InChI=1S/C19H17N3O/c1-21-16-9-5-3-7-14(16)19(23)22-11-10-13-12-6-2-4-8-15(12)20-17(13)18(21)22/h2-9,18,20H,10-11H2,1H3/t18-/m0/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| Evodiamine, (S)-isomer | MeSH | | Isoevodiamine | MeSH |
|
|---|
| Chemical Formula | C19H17N3O |
|---|
| Average Mass | 303.3650 Da |
|---|
| Monoisotopic Mass | 303.13716 Da |
|---|
| IUPAC Name | (1S)-21-methyl-3,13,21-triazapentacyclo[11.8.0.0^{2,10}.0^{4,9}.0^{15,20}]henicosa-2(10),4,6,8,15(20),16,18-heptaen-14-one |
|---|
| Traditional Name | (1S)-21-methyl-3,13,21-triazapentacyclo[11.8.0.0^{2,10}.0^{4,9}.0^{15,20}]henicosa-2(10),4,6,8,15(20),16,18-heptaen-14-one |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | CN1[C@H]2N(CCC3=C2NC2=CC=CC=C32)C(=O)C2=C1C=CC=C2 |
|---|
| InChI Identifier | InChI=1S/C19H17N3O/c1-21-16-9-5-3-7-14(16)19(23)22-11-10-13-12-6-2-4-8-15(12)20-17(13)18(21)22/h2-9,18,20H,10-11H2,1H3/t18-/m0/s1 |
|---|
| InChI Key | TXDUTHBFYKGSAH-SFHVURJKSA-N |
|---|
| Experimental Spectra |
|---|
|
| | Spectrum Type | Description | Depositor Email | Depositor Organization | Depositor | Deposition Date | View |
|---|
| HSQC NMR | [1H, 13C] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | bgnzk@missouri.edu | MU Metabolomics Center, University of Missouri, Columbia. MO, USA | Dr. Bharat Goel | 2023-10-02 | View Spectrum | | HMBC NMR | [1H, 13C] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | bgnzk@missouri.edu | MU Metabolomics Center, University of Missouri, Columbia. MO, USA | Dr. Bharat Goel | 2023-10-02 | View Spectrum | | COSY NMR | [1H, 1H] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | bgnzk@missouri.edu | MU Metabolomics Center, University of Missouri, Columbia. MO, USA | Dr. Bharat Goel | 2023-10-02 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 201 MHz, CDCl3, experimental) | bgnzk@missouri.edu | MU Metabolomics Center, University of Missouri, Columbia. MO, USA | Dr. Bharat Goel | 2023-10-02 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, CDCl3, experimental) | bgnzk@missouri.edu | MU Metabolomics Center, University of Missouri, Columbia. MO, USA | Dr. Bharat Goel | 2023-10-02 | View Spectrum |
| | Predicted Spectra |
|---|
|
| | Spectrum Type | Description | Depositor ID | Depositor Organization | Depositor | Deposition Date | View |
|---|
| 1D NMR | 13C NMR Spectrum (1D, 25 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 252 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 50 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 75 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 101 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 126 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 151 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 176 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 201 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 226 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| | Chemical Shift Submissions |
|---|
|
| Not Available | | Species |
|---|
| Species of Origin | |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as beta carbolines. Beta carbolines are compounds containing a 9H-pyrido[3,4-b]indole moiety. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organoheterocyclic compounds |
|---|
| Class | Indoles and derivatives |
|---|
| Sub Class | Pyridoindoles |
|---|
| Direct Parent | Beta carbolines |
|---|
| Alternative Parents | |
|---|
| Substituents | - Beta-carboline
- Diazanaphthalene
- Quinazoline
- 3-alkylindole
- Indole
- Dialkylarylamine
- Benzenoid
- Pyrrole
- Tertiary carboxylic acid amide
- Vinylogous amide
- Heteroaromatic compound
- Lactam
- Carboxamide group
- Carboxylic acid derivative
- Azacycle
- Organic oxide
- Organic nitrogen compound
- Organopnictogen compound
- Organooxygen compound
- Organonitrogen compound
- Organic oxygen compound
- Hydrocarbon derivative
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Predicted Properties | |
|---|
| General References | - Xu R, Yang X, Tao Y, Luo W, Xiong Y, He L, Zhou F, He Y: Analysis of the Molecular Mechanism of Evodia rutaecarpa Fruit in the Treatment of Nasopharyngeal Carcinoma Using Network Pharmacology and Molecular Docking. J Healthc Eng. 2022 Apr 13;2022:6277139. doi: 10.1155/2022/6277139. eCollection 2022. [PubMed:35463684 ]
- Liu J, Shi Y, Tian Z, Li F, Hao Z, Wen W, Zhang L, Wang Y, Li Y, Fan Z: Bioactivity-Guided Synthesis Accelerates the Discovery of Evodiamine Derivatives as Potent Insecticide Candidates. J Agric Food Chem. 2022 Apr 27;70(16):5197-5206. doi: 10.1021/acs.jafc.1c08297. Epub 2022 Apr 18. [PubMed:35435667 ]
- Li Y, Wang Y, Wang X, Jin L, Yang L, Zhu J, Wang H, Zheng F, Cui H, Li X, Jia Y: Evodiamine suppresses the progression of non-small cell lung carcinoma via endoplasmic reticulum stress-mediated apoptosis pathway in vivo and in vitro. Int J Immunopathol Pharmacol. 2022 Jan-Dec;36:3946320221086079. doi: 10.1177/03946320221086079. [PubMed:35388733 ]
- Liu Y, Wei X, Chen J, Yu YL, Wang JH, Qiu H: Acetylcholinesterase Activity Monitoring and Natural Anti-neurological Disease Drug Screening via Rational Design of Deep Eutectic Solvents and CeO2-Co(OH)2 Nanosheets. Anal Chem. 2022 Apr 19;94(15):5970-5979. doi: 10.1021/acs.analchem.2c00428. Epub 2022 Apr 6. [PubMed:35385268 ]
- Li D, Li Y, Jiang X, Liu W, Zhao Q: Evodiamine-A Privileged Structure with Broad-Ranging Biological Activities. Mini Rev Med Chem. 2022 Apr 4. pii: MRMC-EPUB-122213. doi: 10.2174/1389557522666220404090835. [PubMed:35379148 ]
|
|---|